Compare PRMB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRMB | RGEN |
|---|---|---|
| Founded | 1955 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 10.0B |
| IPO Year | 2025 | 1995 |
| Metric | PRMB | RGEN |
|---|---|---|
| Price | $19.64 | $186.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $24.00 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 4.2M | 853.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | ★ 328.57 | 286.96 |
| EPS | ★ 0.26 | 0.24 |
| Revenue | ★ $6,664,000,000.00 | $141,236,000.00 |
| Revenue This Year | $2.34 | $14.30 |
| Revenue Next Year | $3.56 | $14.52 |
| P/E Ratio | ★ $78.77 | $752.96 |
| Revenue Growth | 29.34 | ★ 35.10 |
| 52 Week Low | $14.36 | $100.99 |
| 52 Week High | $26.21 | $188.73 |
| Indicator | PRMB | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 40.96 | 62.97 |
| Support Level | $20.36 | $158.15 |
| Resistance Level | $21.33 | $188.73 |
| Average True Range (ATR) | 0.87 | 5.68 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 15.15 | 94.17 |
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.